SAN DIEGO, CA, Alida Biosciences, an innovator in epigenomic research tools, announced a $7.5 million Series A funding round.
Alida Biosciences, an innovator in epigenomic research tools, announced a $7.5 million Series A funding round led by Genoa Ventures with participation from FusionX Ventures and Vertical Venture Partners.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
